Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 65,124 | 11,995 |
| Cost of Goods | 29,236 | 5,687 |
| Gross Profit | 35,888 | 6,308 |
| Operating Expenses | 81,375 | 42,845 |
| Operating Income | -45,251 | -35,850 |
| Other Income | -9,505 | -8,249 |
| Pre-tax Income | -54,756 | -44,099 |
| Net Income Continuous | -54,756 | -44,099 |
| Net Income | $-54,756 | $-44,099 |
| EPS Basic Total Ops | -8.60 | -8.31 |
| EPS Basic Continuous Ops | -8.60 | -8.31 |
| EPS Diluted Total Ops | -8.60 | -8.31 |
| EPS Diluted Continuous Ops | -8.60 | -8.31 |
| EPS Diluted Before Non-Recurring Items | -6.49 | N/A |
| EBITDA(a) | $-42,968 | $-33,759 |